Skip to content

Study on optimal duration of use of plantar pump for prevention of lower extremity deep vein thrombosis in patients after orthopedic surgery

Study on optimal duration of use of plantar pump for prevention of lower extremity deep vein thrombosis in patients after orthopedic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055166
Enrollment
Unknown
Registered
2022-01-02
Start date
2021-03-01
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism

Interventions

The experimental group 1:=one hour
The experimental group 2:>one=six hours
The experimental group 3:>six=twelve hours
The experimental group 4:>twelve =eighteen hours
The experimental group5:=eighteen hours

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Elective or emergency orthopedic surgery (outside the upper limb); 3. Caprine score VTE risk assessment =2 points, i.e., patients with moderate, high or extremely high risk of thrombosis; 4. Normal coagulation function, no history of vascular disease, no drug contraindications; 5. Preoperative lower limb vascular ultrasound examination without thrombosis; 6, conscious, can communicate normally, no mental disease or other organic diseases; 7. Actively cooperate to complete the study during the treatment period, and did not participate in other clinical trial observers.

Exclusion criteria

Exclusion criteria: 1. Congestive heart failure, pulmonary edema, or lower limb edema; 2, lower limb deep vein thrombosis, pulmonary embolism or thrombophlebitis; 3. Local abnormalities of lower limbs (such as dermatitis, gangrene, ulcers, cellulitis, infectious wounds, severe deformity of lower limbs, recent skin grafting surgery, etc.); 4. Severe atherosclerosis of lower limb vessels or other ischemic vascular diseases; 5. Abnormal bleeding or coagulation or other recent anticoagulation treatment; 6. Patients with abnormal venous flap function and varicose veins indicated by preoperative color ultrasound of lower limbs; 7. Severe peripheral nerve disease and material allergy.

Design outcomes

Primary

MeasureTime frame
Incidence of venous thromboembolism;

Secondary

MeasureTime frame
Leg circumference;Routine blood;Four coagulation;D-dimer;Fibrinogen concentration;Pain score;

Countries

China

Contacts

Public ContactGaoyuan

Chinese PLA General Hospital

gaoyuanzd@163.com+86 13810548731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026